© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Accolade, Inc. (ACCD) stock remained unchanged at $7.02 a share on NASDAQ. The stock opened at $7.02, fluctuating between $7.02 to $7.02 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 07, 2025 | 7.03 | 7.03 | 7.01 | 7.02 | 4.54M |
| Apr 04, 2025 | 7.02 | 7.03 | 7.01 | 7.03 | 2.29M |
| Apr 03, 2025 | 6.99 | 7.02 | 6.99 | 7.01 | 1.33M |
| Apr 02, 2025 | 6.99 | 7.00 | 6.99 | 6.99 | 368.47K |
| Apr 01, 2025 | 6.99 | 7.00 | 6.98 | 6.99 | 691.83K |
| Mar 31, 2025 | 6.98 | 7.00 | 6.98 | 6.98 | 595.12K |
| Mar 28, 2025 | 6.99 | 7.00 | 6.99 | 6.99 | 360.98K |
| Mar 27, 2025 | 6.98 | 7.00 | 6.98 | 7.00 | 285.14K |
| Mar 26, 2025 | 6.99 | 7.00 | 6.98 | 6.99 | 600.74K |
| Mar 25, 2025 | 7.00 | 7.01 | 6.99 | 6.99 | 222.23K |
| Mar 24, 2025 | 7.00 | 7.01 | 7.00 | 7.00 | 187.24K |
| Mar 21, 2025 | 6.98 | 7.01 | 6.98 | 7.01 | 1.34M |
| Mar 20, 2025 | 7.00 | 7.00 | 6.98 | 6.99 | 561.95K |
| Mar 19, 2025 | 6.99 | 7.00 | 6.99 | 6.99 | 480.5K |
| Mar 18, 2025 | 6.98 | 7.00 | 6.98 | 7.00 | 1.29M |
| Mar 17, 2025 | 6.99 | 7.00 | 6.98 | 7.00 | 675.48K |
| Mar 14, 2025 | 6.99 | 6.99 | 6.98 | 6.98 | 518.9K |
| Mar 13, 2025 | 6.98 | 6.99 | 6.98 | 6.98 | 666.47K |
| Mar 12, 2025 | 6.97 | 6.99 | 6.97 | 6.98 | 624.16K |
| Mar 11, 2025 | 6.96 | 6.97 | 6.96 | 6.96 | 855.9K |
Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.
| Employees | 2400 |
| Beta | 2.1 |
| Sales or Revenue | $414.29M |
| 5Y Sales Change% | 1.297% |
| Fiscal Year Ends | February |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |